Biopharmaceutical Industry Emerging Technologies, Trends and Macroeconomic Factors to Dominate in 2024: Cell and Gene Therapies will be the Key Focus in 2024
January 17, 2024 11:38 ET
|
Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "State of the Biopharmaceutical Industry 2024 Edition" report has been added to ResearchAndMarkets.com's offering.While the fight against COVID-19 is...
Microbiome Market Trends Report 2023: Emerging Therapeutics and Omics-based Research Spotlighting Global Progress
January 09, 2024 06:14 ET
|
Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "2023 Microbiome Market Trend" report has been added to ResearchAndMarkets.com's offering. New research findings delve into the swiftly expanding...
Axial Therapeutics to Present at Upcoming Conferences
January 05, 2024 08:05 ET
|
Axial Therapeutics
WOBURN, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Axial Therapeutics, a clinical-stage biotechnology company dedicated to the development of gut-targeted, small molecule therapeutics for neurological...
Microbiome Therapeutics Market Size to Hit $813.38 Million, Globally, by 2030 - Exclusive Report by The Insight Partners
November 10, 2023 05:43 ET
|
The Insight Partners
Pune, India, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Microbiome therapeutics, also referred to as microbiome-based therapies or interventions, are medical procedures that try to use the human microbiome's...
L’Alliance Promotion Microbiote accueille Ferring Pharmaceuticals, Pelican Health et Polepharma en tant que nouveaux membres
November 09, 2023 10:00 ET
|
ALLIANCE PROMOTION MICROBIOTE
Lyon- France – 9 novembre 2023 – L’Alliance Promotion Microbiote (APM), acteur majeur dédié au développement, à la production et à la commercialisation d’innovations thérapeutiques basées sur le...
Alliance Promotion Microbiote To Welcome Ferring Pharmaceuticals, Pelican Health and Polepharma as New Members
November 09, 2023 10:00 ET
|
ALLIANCE PROMOTION MICROBIOTE
Lyon – France, November 9th, 2023 – Alliance Promotion Microbiote (APM), a leading player dedicated to the development, the production, and the commercialization of therapeutic innovations based on...
Human Microbiome Market to hit USD 6.5 billion by 2032, says Global Market Insights Inc.
October 31, 2023 07:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Human Microbiome Market size will be worth over USD 6.5 billion by 2032. In the current era of scientific advancement, understanding the...
Growing Prevalence of Mental Health Disorders and Advancements in Medical Technology Drive the Global Psychobiotics Market to 2033
October 11, 2023 04:28 ET
|
Research and Markets
Dublin, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The "Psychobiotics Market By Psychotropic Agent, By Form, By Application, and by Region - Global Forecast to 2023-2033" report has been added to ...
Axial Therapeutics Announces Completion of Enrollment in Global Phase 2b Clinical Trial for AB-2004 for Irritability Associated with Autism
September 26, 2023 08:00 ET
|
Axial Therapeutics
– Topline clinical data anticipated in 1Q 2024 – – First-in-class small molecule therapeutic targets the microbiome gut-brain axis and its role in autism, offering a potential alternative to...
Global Live Biotherapeutic Products and Microbiome CDMO Market 2023-2029: Biose Industrie and List Biological Laboratories Shape Diabetes Application Market Share
August 10, 2023 06:08 ET
|
Research and Markets
Dublin, Aug. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Live Biotherapeutic Products And Microbiome CDMO Market Size, Share & Industry Trends Analysis Report By Application (C.difficile, Crohns...